Bristol-Myers - A Strong Buy For Growth Income
May 25, 2020 at 15:09 PM EDT
Bristol-Myers Squibb Company is a biopharmaceutical company with a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, asserts Crista Huff, editor of Cabot Undervalued Stocks Advisor.